Abcam

Abcam Limited
Formerly	Abcam Limited (1998–2005); Abcam plc (2005–2023);
Company type	Subsidiary
Traded as	AIM: ABC; Nasdaq: ABCM;
Industry	Biotechnology; Life sciences;
Founded	1998
Founders	Jonathan Milner; Tony Kouzarides; David Cleevely;
Headquarters	Cambridge Biomedical Campus, Cambridge, UK
Key people	Markus Lusser (President)
Products	Research antibodies; Kits and assays for biological research;
Revenue	£361.7 million (2022)
Operating income	£(10.1) million (2022)
Net income	£(8.5) million (2022)
Total assets	£1,057 million (2022)
Total equity	£726.9 million (2022)
Number of employees	1,760 (2022)
Parent	Danaher Corporation (2023–present);
Website	abcam.com; abcamplc.com;

Abcam Limited is a producer, distributor and seller of protein research tools operating worldwide from 13 locations with 1,800 employees of which 400 work in Research and Development (R&D). Abcam was listed on the Nasdaq and the London Stock Exchange until it was acquired by Danaher Corporation in 2023.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.